| Endothelial-to-mesenchymal transition contributes to cardiac fibrosis EM Zeisberg, O Tarnavski, M Zeisberg, AL Dorfman, JR McMullen, ... Nature medicine 13 (8), 952-961, 2007 | 2524 | 2007 |
| Effects of explosive brain death on cytokine activation of peripheral organs in the RAT1 M Takada, KC Nadeau, WW Hancock, HS Mackenzie, GD Shaw, ... Transplantation 65 (12), 1533-1542, 1998 | 537 | 1998 |
| Role of the PD-1 pathway in the immune response LV Riella, AM Paterson, AH Sharpe, A Chandraker American Journal of Transplantation 12 (10), 2575-2587, 2012 | 531 | 2012 |
| The promise of organ and tissue preservation to transform medicine S Giwa, JK Lewis, L Alvarez, R Langer, AE Roth, GM Church, ... Nature biotechnology 35 (6), 530-542, 2017 | 495 | 2017 |
| Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance T Wekerle, MH Sayegh, J Hill, Y Zhao, A Chandraker, KG Swenson, ... The Journal of experimental medicine 187 (12), 2037-2044, 1998 | 408 | 1998 |
| A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1 WC Goggins, MA Pascual, JA Powelson, C Magee, N Tolkoff-Rubin, ... Transplantation 76 (5), 798-802, 2003 | 294 | 2003 |
| The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. M Takada, A Chandraker, KC Nadeau, MH Sayegh, NL Tilney The Journal of clinical investigation 100 (5), 1199-1203, 1997 | 290 | 1997 |
| Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report AR Tambur, P Campbell, FH Claas, S Feng, HM Gebel, AM Jackson, ... American Journal of Transplantation 18 (7), 1604-1614, 2018 | 250 | 2018 |
| The programmed death-1 ligand 1: B7-1 pathway restrains diabetogenic effector T cells in vivo AM Paterson, KE Brown, ME Keir, VK Vanguri, LV Riella, A Chandraker, ... The Journal of Immunology 187 (3), 1097-1105, 2011 | 242 | 2011 |
| Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients1, 2 S Korom, I De Meester, THW Stadlbauer, A Chandraker, M Schaub, ... Transplantation 63 (10), 1495-1500, 1997 | 239 | 1997 |
| CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous … SJ Khoury, E Akalin, A Chandraker, LA Turka, PS Linsley, MH Sayegh, ... Journal of immunology (Baltimore, Md.: 1950) 155 (10), 4521-4524, 1995 | 238 | 1995 |
| Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. H Azuma, A Chandraker, K Nadeau, WW Hancock, CB Carpenter, ... Proceedings of the National Academy of Sciences 93 (22), 12439-12444, 1996 | 216 | 1996 |
| CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis J Reynolds, FWK Tam, A Chandraker, J Smith, AM Karkar, J Cross, ... The Journal of clinical investigation 105 (5), 643-651, 2000 | 198 | 2000 |
| Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology AJB Watts, KH Keller, G Lerner, I Rosales, AB Collins, M Sekulic, ... Journal of the American Society of Nephrology 33 (1), 238-252, 2022 | 186 | 2022 |
| Pharmacoepidemiology of anemia in kidney transplant recipients WC Winkelmayer, R Kewalramani, M Rutstein, S Gabardi, T Vonvisger, ... Journal of the American Society of Nephrology 15 (5), 1347-1352, 2004 | 185 | 2004 |
| The APOL1 genotype of African American kidney transplant recipients does not impact 5‐year allograft survival BT Lee, V Kumar, TA Williams, R Abdi, A Bernhardy, C Dyer, S Conte, ... American journal of transplantation 12 (7), 1924-1928, 2012 | 177 | 2012 |
| The novel costimulatory programmed death ligand 1/B7. 1 pathway is functional in inhibiting alloimmune responses in vivo J Yang, LV Riella, S Chock, T Liu, X Zhao, X Yuan, AM Paterson, ... The Journal of Immunology 187 (3), 1113-1119, 2011 | 172 | 2011 |
| ANTI-CD154 OR CTLA4Ig OBVIATES THE NEED FOR THYMIC IRRADIATION IN A NON-MYELOABLATIVE CONDITIONING REGIMEN FOR THE INDUCTION OF MIXED HEMATOPOIETIC CHIMERISM AND TOLERANCE1 T Wekerle, MH Sayegh, H Ito, J Hill, A Chandraker, DA Pearson, ... Transplantation 68 (9), 1348-1355, 1999 | 163 | 1999 |
| Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model LV Riella, T Liu, J Yang, S Chock, T Shimizu, B Mfarrej, I Batal, X Xiao, ... American Journal of Transplantation 12 (4), 846-855, 2012 | 153 | 2012 |
| Cutting edge: recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade A Yamada, A Chandraker, TM Laufer, AJ Gerth, MH Sayegh, ... The Journal of Immunology 167 (10), 5522-5526, 2001 | 150 | 2001 |
